# Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer

> **NCT01431196** · PHASE2 · COMPLETED · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 29 (actual)

## Conditions studied

- Stage II Breast Cancer
- Stage III Breast Cancer

## Interventions

- **BIOLOGICAL:** Autologous dendritic cell vaccination

## Key facts

- **NCT ID:** NCT01431196
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-06
- **Final completion:** 2013-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01431196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01431196, "Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01431196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*